CBD for Sleep: Current Evidence and Considerations
Last reviewed: March 21, 2026, 7:02 a.m.
Cannabidiol (CBD) has become one of the most popular sleep supplements in recent years, with surveys indicating that improved sleep is the most commonly cited reason for CBD use among consumers. This surge in popularity has outpaced the scientific evidence, creating a gap between marketing claims and what research has actually demonstrated. Understanding the current state of evidence can help you make an informed decision about whether CBD might have a role in your sleep routine.
The endocannabinoid system (ECS) is involved in numerous physiological processes including sleep-wake regulation, pain modulation, anxiety, and inflammation. Unlike THC, CBD does not produce intoxication and has a complex pharmacological profile, interacting with serotonin receptors (5-HT1A), vanilloid receptors (TRPV1), and adenosine reuptake mechanisms, among others. Its relationship with sleep appears to be dose-dependent and somewhat paradoxical: lower doses (15 to 25 mg) have been reported to be mildly alerting in some studies, while higher doses (75 to 300 mg) appear to have sedating properties. A frequently cited 2019 case series by Shannon et al. in The Permanente Journal found that 25 mg of CBD daily was associated with improved sleep scores in 66.7% of 72 adult participants over the first month, though anxiety scores also improved, making it difficult to determine whether CBD was directly affecting sleep or indirectly improving it by reducing anxiety.
The most robust evidence for CBD and sleep involves its anxiolytic properties rather than direct sedative effects. Anxiety is one of the most common contributors to insomnia, and by reducing the hyperarousal that interferes with sleep onset, CBD may indirectly support better sleep in individuals whose sleep difficulties are anxiety-driven. A 2019 double-blind, placebo-controlled study found that 300 mg of CBD significantly reduced anxiety in a simulated public speaking test. For pain-related sleep disruption, early-stage research suggests that CBD's anti-inflammatory and analgesic properties may help reduce nighttime pain that fragments sleep, though large-scale randomized controlled trials specifically examining this relationship are still lacking.
Product quality is a significant concern in the CBD market. A 2020 study published in the Journal of the American Medical Association analyzed 84 CBD products and found that only 31% were accurately labeled for CBD content. Some products contained significantly more or less CBD than stated, and several contained detectable levels of THC despite being labeled as THC-free. If you choose to try CBD for sleep, look for products that provide certificates of analysis (COAs) from independent laboratories, and verify that the COA matches the specific batch number on your product. Full-spectrum products contain small amounts of THC and other cannabinoids, which some researchers believe may enhance CBD's effects through the entourage effect, while broad-spectrum and isolate products remove THC entirely.
There are important practical and safety considerations for CBD use. CBD is metabolized by the cytochrome P450 enzyme system, meaning it can interact with a wide range of medications, including blood thinners, certain heart medications, and immunosuppressants. If you take prescription medications, consulting with your pharmacist before starting CBD is essential. Side effects are generally mild and may include dry mouth, reduced appetite, drowsiness, and gastrointestinal discomfort. The regulatory landscape for CBD varies by jurisdiction, and the FDA has not approved CBD as a dietary supplement, which contributes to the quality control challenges described above. Given the current state of evidence, CBD may be worth considering for sleep difficulties that are primarily driven by anxiety or pain, but it should not be viewed as a first-line supplement for straightforward insomnia when better-studied options like melatonin, magnesium, and L-theanine are available.
The endocannabinoid system (ECS) is involved in numerous physiological processes including sleep-wake regulation, pain modulation, anxiety, and inflammation. Unlike THC, CBD does not produce intoxication and has a complex pharmacological profile, interacting with serotonin receptors (5-HT1A), vanilloid receptors (TRPV1), and adenosine reuptake mechanisms, among others. Its relationship with sleep appears to be dose-dependent and somewhat paradoxical: lower doses (15 to 25 mg) have been reported to be mildly alerting in some studies, while higher doses (75 to 300 mg) appear to have sedating properties. A frequently cited 2019 case series by Shannon et al. in The Permanente Journal found that 25 mg of CBD daily was associated with improved sleep scores in 66.7% of 72 adult participants over the first month, though anxiety scores also improved, making it difficult to determine whether CBD was directly affecting sleep or indirectly improving it by reducing anxiety.
The most robust evidence for CBD and sleep involves its anxiolytic properties rather than direct sedative effects. Anxiety is one of the most common contributors to insomnia, and by reducing the hyperarousal that interferes with sleep onset, CBD may indirectly support better sleep in individuals whose sleep difficulties are anxiety-driven. A 2019 double-blind, placebo-controlled study found that 300 mg of CBD significantly reduced anxiety in a simulated public speaking test. For pain-related sleep disruption, early-stage research suggests that CBD's anti-inflammatory and analgesic properties may help reduce nighttime pain that fragments sleep, though large-scale randomized controlled trials specifically examining this relationship are still lacking.
Product quality is a significant concern in the CBD market. A 2020 study published in the Journal of the American Medical Association analyzed 84 CBD products and found that only 31% were accurately labeled for CBD content. Some products contained significantly more or less CBD than stated, and several contained detectable levels of THC despite being labeled as THC-free. If you choose to try CBD for sleep, look for products that provide certificates of analysis (COAs) from independent laboratories, and verify that the COA matches the specific batch number on your product. Full-spectrum products contain small amounts of THC and other cannabinoids, which some researchers believe may enhance CBD's effects through the entourage effect, while broad-spectrum and isolate products remove THC entirely.
There are important practical and safety considerations for CBD use. CBD is metabolized by the cytochrome P450 enzyme system, meaning it can interact with a wide range of medications, including blood thinners, certain heart medications, and immunosuppressants. If you take prescription medications, consulting with your pharmacist before starting CBD is essential. Side effects are generally mild and may include dry mouth, reduced appetite, drowsiness, and gastrointestinal discomfort. The regulatory landscape for CBD varies by jurisdiction, and the FDA has not approved CBD as a dietary supplement, which contributes to the quality control challenges described above. Given the current state of evidence, CBD may be worth considering for sleep difficulties that are primarily driven by anxiety or pain, but it should not be viewed as a first-line supplement for straightforward insomnia when better-studied options like melatonin, magnesium, and L-theanine are available.